Shots: The P-III OASIS-2 study involves assessing of Nuzyra (qd, PO) vs Linezolid (PO, bid) in 735 patients with acute bacterial skin and skin structure infections (ABSSSI) The P-III OASIS […]readmore
Tags : Skin Infections
Shots: The P-III OPTIC and OASIS-1 studies involves assessing of Nuzyra (Omadacycline) vs moxifloxacin & linezolid in 386 & 645 patients with community acquired bacterial pneumonia (CABP) & acute bacterial […]readmore